Clinical Trial

Pelargonium Graveolens Essential Oil as a Pulpotomy Agent in Primary Teeth

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The success of pulpotomy in primary teeth is critical for preserving function and arch integrity in children and depends largely on the biological properties of the medicament used. Given the limitations of mineral trioxide aggregate, Pelargonium graveolens essential oil has emerged as a potential alternative; however, its clinical performance as a pulpotomy agent remains insufficiently investigated.
Trial Details
NCT Number NCT07386925
Lead Sponsor Tanta University
Conditions Pulpitis - Reversible, Pulpotomies on Primary Molars
Enrollment 30 participants
Start Date 2026-02
Primary Completion 2026-10 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-02-04